Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
Irene Li(Stanford University), Barzin Y. Nabet(Gene Therapy Laboratory)
Cited by 408
Related Papers
Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities
|Cancer Cell|2021|930
Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways
|Cell|2014|798